Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (148)

« Back to Publications

Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic disease.

Hammami I. et al, (2025), Heart, 111, 716 - 721

Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank.

Camm CF. et al, (2025), Europace, 27

Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction.

Valdes-Marquez E. et al, (2023), Eur J Prev Cardiol, 30, 583 - 591

polipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease.

Clarke R. et al, (2023), Circ Res, 132, 452 - 464

Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic Epidemiology.

Staplin N. et al, (2022), Hypertension, 79, 2671 - 2681

Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.

Aragam KG. et al, (2022), Nat Genet, 54, 1803 - 1815

Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries.

Mishra A. et al, (2022), Nature, 612

Stroke genetics informs drug discovery and risk prediction across ancestries.

Mishra A. et al, (2022), Nature, 611, 115 - 123

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Cholesterol Treatment Trialists' Collaboration ., (2022), Lancet, 400, 832 - 845

Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.

Clarke R. et al, (2022), Atherosclerosis, 354, 15 - 22

Independent effects of adiposity measures on risk of atrial fibrillation in men and women: a study of 0.5 million individuals.

Camm CF. et al, (2022), Int J Epidemiol, 51, 984 - 995

Multi-phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations.

Temprano-Sagrera G. et al, (2022), J Thromb Haemost, 20, 1331 - 1349

e polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?

Tapela NM. et al, (2022), Eur J Prev Cardiol, 29, 925 - 937

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

HPS3/TIMI55-REVEAL Collaborative Group . et al, (2022), Eur Heart J, 43, 1416 - 1424

Genetic associations of adult height with risk of cardioembolic and other subtypes of ischemic stroke: A mendelian randomization study in multiple ancestries.

Linden AB. et al, (2022), PLoS Med, 19

Load More

1
2
3
4
5
6
7
...
»